Sg3 Management, LLC Astrazeneca PLC Put Options Transaction History

Sg3 Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $5.01 Million - $6.03 Million	-89,900 Reduced 48.52%	95,400 $6.33 Million
Q4 2021 Feb 15, 2022	BUY	$54.02 - $63.83 $1.98 Million - $2.34 Million	36,700 Added 24.7%	185,300 $10.8 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $1.11 Million - $1.22 Million	-20,000 Reduced 11.86%	148,600 $8.93 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $968,400 - $1.2 Million	20,000 Added 13.46%	168,600 $10.1 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $7.01 Million - $8.09 Million	148,600 New	148,600 $7.39 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $2.65 Million - $3.06 Million	-50,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $2.16 Million - $2.77 Million	50,000 New	50,000 $2.65 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.